{"schema_version":"secwatch.filing_event.v1","accession":"0001428336-23-000020","form_type":"8-K","ticker":"HQY","cik":"0001428336","company_name":"HEALTHEQUITY, INC.","filed_at":"2023-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.832422+00:00","generated_at":"2026-06-14T07:16:25.270809+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"HealthEquity Q1 revenue $244.4M (+19%), net income $4.1M vs loss, raises FY guidance","bullets":["Revenue $244.4M (+19% YoY); GAAP EPS $0.05; non-GAAP EPS $0.50 vs $0.27.","Adjusted EBITDA $86.6M (+48%), margin 35% vs 28%.","HSA accounts 8.0M (+9%); total HSA assets $22.3B (+10%).","FY2024 guidance raised: revenue $975-985M, Adj. EBITDA $333-343M, non-GAAP EPS $1.88-$1.97.","Early repaid $50M variable-rate debt; cites strong profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0001428336-23-000020","json":"https://secwatch.observer/filing/0001428336-23-000020.json","markdown":"https://secwatch.observer/filing/0001428336-23-000020.md","text":"https://secwatch.observer/filing/0001428336-23-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000020/0001428336-23-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000020/hqy-20230605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T07:16:25.270809+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"16e5078e9c9f664aba45c838c55d34e4cb81e37d","claim":"HEALTHEQUITY, INC. reported fiscal year ending January 31, 2024 results: revenue $975 million to $985 million, net income $9 million and $14 million, EPS $0.10 to $0.16 per diluted share. Guidance raised.","evidence_excerpt":"For the fiscal year ending January 31, 2024, management expects revenue of $975 million to $985 million. Its outlook for net income is between $9 million and $14 million, resulting in net income of $0.10 to $0.16 per diluted share.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000020/0001428336-23-000020-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ending January 31, 2024"},{"label":"Revenue","value":"$975 million to $985 million"},{"label":"Net income","value":"$9 million and $14 million"},{"label":"EPS","value":"$0.10 to $0.16 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"87b2d147b291fd8e3fc04c3a29d98a145b78a9b7","claim":"HEALTHEQUITY, INC. reported results: revenue $244.4 million, net income $4.1 million, EPS $0.05 per diluted share. Guidance raised.","evidence_excerpt":"in such a filing. --- EX-99.1 (EX-99.1) --- HealthEquity Reports First Quarter Ended April 30, 2023 Financial Results Highlights of the first quarter include: • Revenue of $244.4 million, an increase of 19% compared to $205.7 million in Q1 FY23. • Net income of $4.1 million, compared to net loss of $13.6 million in Q1 FY23, with non-GAAP net income of $42.8","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000142833623000020/0001428336-23-000020-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Revenue","value":"$244.4 million"},{"label":"Net income","value":"$4.1 million"},{"label":"EPS","value":"$0.05 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}